Location: Home / Volume 4 Part 1: Question 3
Part 1: Current Approach to Treating Chronic Myeloid Leukemia
Jack W. Erter, III, MD, and Ramiro Garzon, MD
Drs. Erter and Garzon are fellows; both are at the Division of Hematology/Oncology, Comprehensive Care Center, Ohio State University, Columbus, OH.
Question 3
Which of the following statements best characterizes the side effects associated with nilotinib treatments?
